Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2008
11/20/2008WO2008121687A3 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
11/20/2008WO2008114011A3 Fc polypeptide variants obtained by ribosome display methodology
11/20/2008WO2008109382B1 Nucleic acid compounds for inhibiting pkn3 gene expression and uses thereof
11/20/2008WO2008109376B1 Nucleic acid compounds for inhibiting bcr-abl gene expression and uses thereof
11/20/2008WO2008108910A3 Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy
11/20/2008WO2008100562A3 Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cells
11/20/2008WO2008085828A3 Peptide modulators of angiogenesis and use thereof
11/20/2008WO2008077956A3 Oligonucleotide-, protein and/or peptide-polymer conjugates
11/20/2008WO2008070313A3 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
11/20/2008WO2008058993A3 Use of alpha ketogluaric acid for the treatment of infection with h. pylori
11/20/2008WO2008031817A3 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors
11/20/2008WO2007129019A8 Sulfonamide compounds useful as edg receptor modulators
11/20/2008WO2007109661A3 Methods of preparation and resolution of e/z isomers of vinylfuro[2,3-d] pyrimidine and their biological activities
11/20/2008WO2007075077A8 Use of transcriptome-modifying agents and chemotherapy or radiotherapy against cancer
11/20/2008US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods
11/20/2008US20080288627 Storage network and method for storage network device mapping
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287541 Kit for Treatment of Cancer
11/20/2008US20080287532 Oxacyclopentene-2 derivatives
11/20/2008US20080287528 Therapeutic methods and compositions involving isoflavones
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008US20080287518 Use of a Benzoyl Derivative of 3-Aminocarbazole For the Treatment of a Disorder Associated With the Production of Prostaglandin E2 (Pge2)
11/20/2008US20080287501 Therapeutic uses of an insulin secretion enhancer
11/20/2008US20080287496 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
11/20/2008US20080287495 Novel benzo[d][1,3]-dioxol derivatives
11/20/2008US20080287492 Alkylpyridyl Quinolines as Nk3 Receptor Modulators
11/20/2008US20080287482 Production of Polyketides and Other Natural Products
11/20/2008US20080287476 Administration of dipeptidyl peptidase inhibitors
11/20/2008US20080287475 4-(3-Aminopyrazole) Pyrimidine Derivatives for Use as Tyrosine Kinase Inhibitors in the Treatment of Cancer
11/20/2008US20080287474 Antiproliferative Pyrimidyl, Fused Pyrimidyl and Pyrimidyl Hydrazones
11/20/2008US20080287468 Purine and imidazopyridine derivatives for immunosuppression
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287457 Inhibitors of Akt Activity
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287439 Pyrimidine compounds
11/20/2008US20080287437 Pyrazolylaminopyrimidine Derivatives Useful as Tyrosine Kinase Inhibitors
11/20/2008US20080287431 Heterocyclic Compound and Anti-Malignant-Tumor Agent Containing the Same as Active Ingredient
11/20/2008US20080287420 Cyclopamine lactam analogs and methods of use thereof
11/20/2008US20080287419 Apoptosis promoters
11/20/2008US20080287415 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
11/20/2008US20080287414 Mitotic Kinesin Inhibitors
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287383 Nucleic acid compounds for inhibiting erbb gene expression and uses thereof
11/20/2008US20080287378 Solid state forms of 5-azacytidine and processes for preparation thereof
11/20/2008US20080287374 Breast cancer-resistant protein inhibitor
11/20/2008US20080287353 Peptides and proteins for early liver development and antibodies thereto
11/20/2008US20080287346 Bioactive peptides
11/20/2008US20080287344 Use of Amino Acids for Making Medicines for Treating Insulin Resistance
11/20/2008US20080286806 Ligand for G-protein coupled receptor GPR43 and uses thereof
11/20/2008US20080286804 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
11/20/2008US20080286789 Genomic polymorphism for predicting therapeutic response
11/20/2008US20080286781 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
11/20/2008US20080286388 Herbal extracts; for relief of allergy, ache, cold, viral infection, thrombus or clotting, inflammation, cancer, intoxication, memory decay, caffeine dependence
11/20/2008US20080286387 Standardized method for recovering enriched Indian date extract (IDE), properties of IDE and applications thereof
11/20/2008US20080286351 Pegylated Cardiolipin Analogs, Methods of Synthesis, and Uses Thereof
11/20/2008US20080286314 Dendritic cells loaded with heat shocked melanoma cell bodies
11/20/2008US20080286313 Peptide Vaccines for the Treatment of Cancers
11/20/2008US20080286296 Cyclic-Dinucleotides and Its Conjugates as Adjuvants and Their Uses in Pharmaceutical Compositions
11/20/2008US20080286292 Molecular vaccine linking intercellular spreading protein to an antigen
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286287 Methods and Agents for Modulating Cellular Activity
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286283 Treatment of cancer with antibodies to costimulating polypeptide of T cells
11/20/2008US20080286282 Novel Use of Sulfonamide Compound in Combination with Angiogenesis Inhibitor
11/20/2008US20080286277 Monoclonal antibody comprising specificity determining residues for targeting tumor cells for destruction
11/20/2008US20080286273 Knowledge-Based Proliferation Signatures and Methods of Use
11/20/2008US20080286272 EphA3 Antibodies for the Treatment of Solid Tumors
11/20/2008US20080286265 Substituted phenoxy n-alkylated thiazolidinediones as estrogen related receptor-alpha modulators
11/20/2008US20080286257 Compounds for Use in Treating Abnormal Cell Proliferation, and Methods of Producing Same
11/20/2008US20080286251 Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins
11/20/2008US20080286247 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
11/20/2008US20080286239 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/20/2008US20080286237 Systemic Treatment of Metastatic and/or Systemically-Disseminated Cancers using GM-CSF-Expressing Poxviruses
11/20/2008US20080286232 Methods for treating sarcoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
11/20/2008US20080286228 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/20/2008US20080286198 Novel anti-IGF-IR antibodies and uses thereof
11/20/2008CA2723671A1 Tubulysine derivatives
11/20/2008CA2687410A1 Uses of north american ginseng fractions for treating leukemia
11/20/2008CA2687403A1 Carbohydrate-containing pan cancer marker
11/20/2008CA2687007A1 Polymerase inhibitors and the use thereof for the treatment of tumors
11/20/2008CA2686908A1 Rna antagonist compounds for the modulation of her3
11/20/2008CA2686903A1 Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitors
11/20/2008CA2686848A1 Methods of treatment using intravenous formulations comprising temozolomide
11/20/2008CA2686768A1 Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
11/20/2008CA2686766A1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
11/20/2008CA2686489A1 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/20/2008CA2685994A1 Single-chain circular rna and method of producing the same
11/20/2008CA2685757A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008CA2685520A1 Tetrahydrofuro [3 4-d] dioxolane compounds for use in the treatment of viral infections and cancer
11/20/2008CA2685351A1 Inhibitors of protein kinases
11/20/2008CA2684932A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors
11/20/2008CA2684666A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
11/20/2008CA2684114A1 Use of hdac inhibitors for the treatment of melanoma
11/20/2008CA2683590A1 Compositions that include a hydrophobic compound and a polyamino acid conjugate
11/20/2008CA2683568A1 Cysteine engineered anti-muc16 antibodies and antibody drug conjugates
11/20/2008CA2683195A1 Mono-hydrochloric salts of an inhibitor of histone deacetylase
11/20/2008CA2678335A1 Solid forms of a raf kinase inhibitor
11/20/2008CA2673133A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
11/20/2008CA2667447A1 Mapk/erk kinase inhibitors
1 ... 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 ... 2211